Free Trial
TSE:EDT

Spectral Medical (EDT) Stock Price, News & Analysis

C$0.50
-0.02 (-3.85%)
(As of 07/26/2024 ET)
Today's Range
C$0.49
C$0.51
50-Day Range
C$0.47
C$0.52
52-Week Range
C$0.30
C$0.67
Volume
85,841 shs
Average Volume
78,734 shs
Market Capitalization
C$139.70 million
P/E Ratio
N/A
Dividend Yield
1.45%
Price Target
N/A
EDT stock logo

About Spectral Medical Stock (TSE:EDT)

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

EDT Stock Price History

EDT Stock News Headlines

“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
EDT:CA Spectral Medical Inc.
“Generational Bull Run” Incoming
LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.
Q4 2023 Spectral AI Inc Earnings Call
See More Headlines
Receive EDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectral Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2024
Today
7/26/2024
Next Earnings (Estimated)
8/08/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
29
Year Founded
N/A

Profitability

Net Income
C$-18,570,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$1.74 million
Cash Flow
C$0.01 per share
Book Value
C($0.07) per share

Miscellaneous

Free Float
N/A
Market Cap
C$139.70 million
Optionable
Not Optionable
Beta
0.91
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

EDT Stock Analysis - Frequently Asked Questions

How have EDT shares performed this year?

Spectral Medical's stock was trading at C$0.43 at the start of the year. Since then, EDT stock has increased by 17.6% and is now trading at C$0.50.
View the best growth stocks for 2024 here
.

How were Spectral Medical's earnings last quarter?

Spectral Medical Inc. (TSE:EDT) issued its quarterly earnings results on Monday, May, 13th. The company reported ($0.01) earnings per share for the quarter. The firm earned $0.67 million during the quarter.

How do I buy shares of Spectral Medical?

Shares of EDT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of Spectral Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Spectral Medical investors own include Aurora Cannabis (ACB), CENTRIC HEALTH (CHH), Cequence Energy Ltd. (CQE.TO) (CQE), Cenovus Energy (CVE), Enbridge (ENB), Absolute Software Co. (ABT.TO) (ABT) and Air Canada (AC).

This page (TSE:EDT) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners